Posted inStock
Sana Biotech’s islet cell therapy shows promise in diabetes; shares surge 150% postmarket
Shares of Sana Biotechnology surged 150% on Tuesday postmarket after preliminary results from a novel clinical study that may have significant implications for the treatment of type 1 diabetes. Conducted…